cilostazol has been researched along with Tachycardia, Ventricular in 4 studies
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypothermia has been reported to induce ventricular tachycardia and fibrillation (VT/VF) in patients with early repolarization (ER) pattern." | 5.40 | Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. ( Antzelevitch, C; Gurabi, Z; Koncz, I; Nesterenko, VV; Patocskai, B, 2014) |
| "Hypothermia has been reported to induce ventricular tachycardia and fibrillation (VT/VF) in patients with early repolarization (ER) pattern." | 1.40 | Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone. ( Antzelevitch, C; Gurabi, Z; Koncz, I; Nesterenko, VV; Patocskai, B, 2014) |
| "Cilostazol was discontinued, and shortly thereafter the ventricular tachycardia subsided." | 1.31 | Rapid ventricular tachycardias associated with cilostazol use. ( Gamssari, F; Garcia, E; Ho, JS; Liu, B; Mahmood, H; Massumi, A; Rasekh, A; Villareal, RP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, K | 1 |
| Miyazaki, S | 1 |
| Ishikawa, E | 1 |
| Mukai, M | 1 |
| Aoyama, D | 1 |
| Nodera, M | 1 |
| Kaseno, K | 1 |
| Tada, H | 1 |
| Gurabi, Z | 2 |
| Koncz, I | 2 |
| Patocskai, B | 2 |
| Nesterenko, VV | 1 |
| Antzelevitch, C | 2 |
| Barajas-Martinez, H | 1 |
| Hu, D | 1 |
| Gamssari, F | 1 |
| Mahmood, H | 1 |
| Ho, JS | 1 |
| Villareal, RP | 1 |
| Liu, B | 1 |
| Rasekh, A | 1 |
| Garcia, E | 1 |
| Massumi, A | 1 |
4 other studies available for cilostazol and Tachycardia, Ventricular
| Article | Year |
|---|---|
Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
Topics: Ablation Techniques; Action Potentials; Anti-Arrhythmia Agents; Cilostazol; Defibrillators, Implanta | 2019 |
Cellular mechanism underlying hypothermia-induced ventricular tachycardia/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cilostazol; Disease Models, Animal; Dogs; Electr | 2014 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud | 2016 |
Rapid ventricular tachycardias associated with cilostazol use.
Topics: Aged; Aged, 80 and over; Cilostazol; Female; Humans; Intermittent Claudication; Phosphodiesterase In | 2002 |